Bill Gates slams ‘shocking’ U.S. response to Covid-19 pandemic
The philanthropist, who has long warned of the need to prepare for pandemics, is dumbfounded by the U.S. response so far.
Related Articles
Can investing in infectious disease pay off? Vir Biotechnology’s tightrope walk shows it’s a struggle
In 2017, Vir Biotechnology’s founders threw millions at infectious disease. Covid made them look like geniuses. The road since then has been far rockier.
Mass General Brigham is ready to move on without Dana-Farber, CEO says
The CEO of Mass General Brigham: “Does the Farber departure change things? Absolutely. I would say, however, our commitment remains to patients. We’re going to…
Readers respond to essays on hospital taxes, ADHD in girls and women, and more
In this week’s Letters to the Editor, STAT readers respond to First Opinion essays on hospital taxes, ADHD in girls and women, and more.
Ultragenyx reports early success with Angelman syndrome drug, backing up 2022 acquisition
Ultragenyx has found early success with its experimental treatment for the rare disease Angelman syndrome.
Hospital price transparency rules are seeding a new crop of health tech startups
Hospital and health insurance pricing data surfaced by new federal transparency rules are creating an opportunity for startups to help patients fight exorbitant medical bills.
Covid ignited a global controversy over what is an airborne disease. The WHO just expanded its definition
A WHO advisory committee outlined a new set of definitions that more accurately reflect the science of airborne disease transmission.
Second-generation mosquito nets prevented 13 million malaria cases in large pilot programs
Second-generation mosquito nets prevented 13 million malaria cases and 25,000 deaths in large pilot programs.
H5N1 bird flu in U.S. cattle: A wake-up call to action
Comparisons to seasonal flu management underestimate the unique challenges posed by H5N1 bird flu.
Health disparities and premature deaths run deep, even in best-performing states
A new analysis of health inequities shows that every state has deep racial and ethnic disparities in the performance of their health care systems.
Eli Lilly’s Zepbound eases obstructive sleep apnea in trials
Eli Lilly reported Wednesday that the GLP-1 drug cut breathing interruptions in obese or overweight patients experiencing the condition.